eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Prospective Grant of Exclusive License: Development of a Companion Diagnostic Kit To Detect Asparagine Synthetase Expression Levels as a Method To Screen for the Drug Efficacy in Treatments for Pancreatic Cancer, Ovarian Cancer, and Multiple Myeloma

Prospective Grant of Exclusive License: Development of a Companion Diagnostic Kit To Detect Asparagine Synthetase Expression Levels as a Method To Screen for the Drug Efficacy in Treatments for Pancreatic Cancer, Ovarian Cancer, and Multiple Myeloma

Document ID: NIH_FRDOC_0001-2873
Document Type: Notice
Agency: National Institutes Of Health
Topics: No Topics associated with this document
Federal Register Number: E9-26309
View Document:  View as format pdf View as format html

Details Information

Received Date: November 03 2009, at 09:07 AM Eastern Standard Time
Start-End Page: 56857 - 56858
Page Count: 2
Comment Start Date: November 3 2009, at 12:00 AM Eastern Standard Time
Comment Due Date: January 4 2010, at 11:59 PM Eastern Standard Time

Comments

Total: 0
No comments posted.

Related Documents

Total: 0
No documents available.